Patents by Inventor Jacob J. Plattner

Jacob J. Plattner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4221706
    Abstract: The present invention comprises compounds of the formula ##STR1## and the biologically acceptable acid addition salts thereof, wherein R.sub.1 represents hydrogen or lower alkyl having 1 to 4 carbon atoms; R.sub.2 represents an alkylene having 2 to 4 carbon atoms; R.sub.3 represents amino or guanidino; R.sub.4 represents nitrophenyl, methylnitrophenyl, dinitropheyl, naphthyl, or nitronaphtyl; m is 2 or 3; and n is 3 or 4. The compounds of the present invention are analytical reagents useful for measuring proteolytic enzymes such as thrombin and trypsin. The enzymatic hydrolysis of the invention compounds provides a chromogenic amine by which the proteolytic enzyme concentration can be determined spectrophotometrically.
    Type: Grant
    Filed: June 14, 1979
    Date of Patent: September 9, 1980
    Assignee: Abbott Laboratories
    Inventors: Akhtar Ali, Jacob J. Plattner
  • Patent number: 4219497
    Abstract: The present invention comprises compounds of the formula ##STR1## and the biologically acceptable acid addition salts thereof wherein R.sub.1 represents hydrogen, or lower alkyl having 1-4 carbon atoms; R.sub.2 represents p-hydroxybenzyl or benzyl; R.sub.3 represents an alkyl having 1-6 carbon atoms; R.sub.4 represents amino or guanidino; R.sub.5 represents p-nitrophenyl, methylnitrophenyl, dinitrophenyl, naphthyl, or nitronaphthyl; and n is 3 or 4.
    Type: Grant
    Filed: April 6, 1979
    Date of Patent: August 26, 1980
    Assignee: Abbott Laboratories
    Inventors: Jacob J. Plattner, Stephen D. Stroupe, Houston F. Voss
  • Patent number: 4219483
    Abstract: Novel 2,3,6-substituted-4-pyrones having activity as prostaglandin antagonists are disclosed, together with intermediates useful for the preparation thereof. Methods of using the compounds of this invention as prostaglandin antagonists are described.
    Type: Grant
    Filed: September 11, 1978
    Date of Patent: August 26, 1980
    Assignee: Pfizer Inc.
    Inventors: Donald E. Kuhla, Jacob J. Plattner
  • Patent number: 4169849
    Abstract: 11-Desoxy-15-thia-16-aryl-.omega.-tetranor prostanoid compounds having a carboxyl, tetrazole, or substituted imide at C.sub.1, having prostaglandin-like anti-ulcer activity and their synthesis from the 11-desoxy "Corey Lactone".
    Type: Grant
    Filed: October 27, 1978
    Date of Patent: October 2, 1979
    Assignee: Pfizer Inc.
    Inventor: Jacob J. Plattner
  • Patent number: 4166825
    Abstract: The present invention encompasses acid addition salts of a compound of the formula ##STR1## wherein: R.sub.1 represents phenylsulfonyl, benzoyl, carbobenzoxy, and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, phenyl, or hydroxy substituted derivatives thereof; or alkanoyl having 2-12 carbon atoms; R.sub.2 represents alkyl having 1-10 carbon atoms, alkoxyalkyl having 2-6 carbon atoms, cycloalkyl having 5-7 carbon atoms, benzyl and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, carboxy, hydroxy, or substituted derivatives thereof; R.sub.3 represents hydrogen or guanyl, and m is 3 or 4.Compounds of the present invention are useful as analytical reagents. Enzymatic hydrolysis provides --S--R.sub.2 which can be further reacted with 5,5'-dithiobis (2-nitrobenzoic acid) to provide a colored product by which the enzyme concentration can be determined spectrophotometrically.
    Type: Grant
    Filed: August 17, 1978
    Date of Patent: September 4, 1979
    Assignee: Abbott Laboratories
    Inventors: Jacob J. Plattner, Houston F. Voss, Susan E. Magic
  • Patent number: 4161488
    Abstract: The present invention encompasses the acid addition salts of a compound of the formula ##STR1## wherein R.sub.1 represents phenylsulfonyl, benzoyl, carbobenzoxy, and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, phenyl, or hydroxy substituted derivatives thereof; or alkanoyl having 2-12 carbon atoms; and R.sub.2 represents alkyl having 1-10 carbon atoms, or alkoxyalkyl having 2-6 carbon atoms, cycloalkyl having 5-7 carbon atoms, or benzyl and the halo, loweralkyl having 1-4 carbon atoms, loweralkoxy having 1-3 carbon atoms, hydroxy, carboxy, or phenyl substituted derivatives thereof.Compounds of the present invention are useful as analytical reagents. Enzymatic hydrolysis provides --S--R.sub.2 which can be further reacted with 5,5'-dithiobis (2-nitrobenzoic acid) to provide a colored product by which the enzyme concentration can be determined spectrophotometrically.
    Type: Grant
    Filed: August 17, 1978
    Date of Patent: July 17, 1979
    Assignee: Abbott Laboratories
    Inventors: Jacob J. Plattner, Houston F. Voss, Susan E. Magic
  • Patent number: 4148804
    Abstract: 11-Desoxy-15-thia-16-aryl-.omega.-tetranor prostanoid compounds having a carboxyl, tetrazole, or substituted imide at C.sub.1, having prostaglandin-like anti-ulcer activity and their synthesis from the 11-desoxy "Corey Lactone".
    Type: Grant
    Filed: June 28, 1978
    Date of Patent: April 10, 1979
    Assignee: Pfizer Inc.
    Inventor: Jacob J. Plattner
  • Patent number: 4132847
    Abstract: Novel 2,3,6-substituted-4-pyrones having activity as prostaglandin antagonists are disclosed, together with intermediates useful for the preparation thereof. Methods of using the compounds of this invention as prostaglandin antagonists are described.
    Type: Grant
    Filed: July 22, 1977
    Date of Patent: January 2, 1979
    Assignee: Pfizer Inc.
    Inventors: Donald E. Kuhla, Jacob J. Plattner
  • Patent number: 4129728
    Abstract: 11-Desoxy-15-thia-16-aryl-.omega.-tetranor prostanoid compounds having a carboxyl, tetrazole, or substituted imide at C.sub.1, having prostaglandin-like anti-ulcer activity and their synthesis from the 11-desoxy "Corey Lactone".
    Type: Grant
    Filed: January 11, 1978
    Date of Patent: December 12, 1978
    Assignee: Pfizer Inc.
    Inventor: Jacob J. Plattner
  • Patent number: 4092349
    Abstract: 11-Desoxy-15-thia-16-aryl-.omega.-tetranor prostanoid compounds having a carboxyl, tetrazole, or substituted imide at C.sub.1, having prostaglandin-like anti-ulcer activity and their synthesis from the 11-desoxy "Corey Lactone".
    Type: Grant
    Filed: November 10, 1976
    Date of Patent: May 30, 1978
    Assignee: Pfizer Inc.
    Inventor: Jacob J. Plattner
  • Patent number: 4018758
    Abstract: Racemic 3-aminomethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoli ne carboxylic acid, alkyl, phenyl and benzyl esters as analgesic agents, synthesized from 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quino line carboxylic acid, alkyl, phenyl and benzyl esters and the dextrorotatory enantiomer 3-aminomethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoli ne carboxylic acid, ethyl ester, an outstanding analgesic agent.
    Type: Grant
    Filed: April 12, 1976
    Date of Patent: April 19, 1977
    Assignee: Pfizer Inc.
    Inventors: Michael R. Johnson, Jacob J. Plattner
  • Patent number: 4001263
    Abstract: 2-Substituted-5-aryl-1,2,3,4-tetrahydro-.gamma.-carbolines, their use as tranquilizing agents and the preparation thereof from 5-aryl-1,2,3,4-tetrahydro-.gamma.-carbolines.
    Type: Grant
    Filed: April 9, 1975
    Date of Patent: January 4, 1977
    Assignee: Pfizer Inc.
    Inventors: Jacob J. Plattner, Charles A. Harbert, James R. Tretter
  • Patent number: 3978064
    Abstract: Racemic 3-aminomethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoli ne carboxylic acid, alkyl, phenyl and benzyl esters as analgesic agents, synthesized from 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quino line carboxylic acid, alkyl, phenyl and benzyl esters and the dextrorotatory enantiomer 3-aminomethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoli ne carboxylic acid, ethyl ester, an outstanding analgesic agent.
    Type: Grant
    Filed: November 4, 1975
    Date of Patent: August 31, 1976
    Assignee: Pfizer Inc.
    Inventors: Michael R. Johnson, Jacob J. Plattner